The objective of this one day workshop is to gather a group of experts to 1) review existing data on existing DHIMs; 2) discuss each model’s potential value, risks and limitations; 3) evaluate their possible role in advancing our understanding of dengue pathogenesis and the development of vaccines and drugs; and 4) discuss appropriate avenues for further research.
NIAID/FDA Workshop on Regulatory Issues Related to DengueVaccines
The objective of this one day workshop is to gather a group of experts to 1) review ongoing dengue vaccine clinical trials; 2) discuss different strategies to assess dengue vaccine safety; and 3) discuss current and novel assays to assess vaccine efficacy. The consultation panel will include clinicians, dengue experts, regulatory agencies and developers of dengue vaccines.
Last Updated February 05, 2014
Last Reviewed February 05, 2014